Furthermore, this review highlighted the newly discovered pharmacological effects of BTZ in multiple diseases such as membranous nephropathy, pulmonary hypertension and neurofibromatosis, which accredited BTZ with additional clinical value in cancer and other illnesses. The gene discussed is CASC3; the disease is membranous glomerulonephritis.